BNT162b2 vaccine not only targets COVID-19 virus, but may also help reduce and control innate inflammation

Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended primary target. In a study recently published in the Clinical Immunology journal, researchers found that the vaccine not only targeted the COVID-19 virus, it also unexpectedly helped to reduce and control innate inflammation of other bacterial and fungal pathogens not related to the vaccine target.